Project Grant HT94252310408
Award Date 5/1/23
Completion Date 4/30/26
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
- The University of Houston System received a $999,465 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2029. The award supports research into selective spleen-targeted nanoparticles as drug delivery vehicles for lupus treatment. This research initiative aligns with the DHA's mandate to advance biomedical innovation for military service members and the broader public...
- The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...
- This federal Project Grant award for $999,392.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Houston System. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 4-year grant (9/1/2025 - 8/31/2029) will fund research focused on PRMT5 in lupus nephritis, a serious kidney condition. As a prominent...
- The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
- This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
- The University of Houston System, a Hispanic Serving Institution, was awarded a $604,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting PRMT5 in MTAP-Loss Melanoma." The three-year project, which runs from September 30, 2023 to September 29, 2026, aims to investigate medical solutions for the battlefield through advanced biomedical research to transform health care for service...
- The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,997 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a pharmacology and efficacy study of a novel, blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The Military...
- The U.S. Department of Defense's Defense Health Agency awarded a $749,999 Project Grant to the University of Louisville's Office of Research & Innovation to support the "RESTORATION OF MACROPHAGE FUNCTION AS A STRATEGY TO PREVENT/TREAT LUPUS" research project. The grant, which runs from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). This program supports a range of biomedical research aimed at...
- The University of Houston System received a $750,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Circulating Immune Complexes as Biomarkers for Early Detection and Monitoring of Ovarian Cancer." This 4-year research effort, commencing on May 1, 2025, aims to develop innovative diagnostic tools and clinical practices to address critical health challenges relevant to military...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...